Leveraging Plan Mexico for Long Term Success in Healthcare

Join us in Mexico City at the JW Marriott!

Drawing on FrontierView’s strategic insights and benchmarking, this event will equip healthcare executives with the tools to make informed decisions on market access, investment strategies, and competitive positioning in Mexico.

As we near the end of 2025, companies are under mounting pressure to define their 2026 plans. Executives must weigh the investment opportunities the Sheinbaum administration is trying to foster against persistent risks in Mexico’s political and economic landscape. The groundwork for the 2027–2028 consolidated tender is already underway, while Plan México is setting the framework for the country’s healthcare goals through 2030, creating new opportunities for companies to position themselves strategically. Meanwhile, USMCA renegotiations, diplomatic tensions with the US, and the growing presence of Asian competitors are reshaping pricing dynamics and intensifying competitive pressures across LATAM.

The first half of 2026 is expected to bring improvements in COFEPRIS approval timelines and the full implementation of administrative updates to the Compendio Nacional, with significant implications for market access. Meanwhile, the shift toward low-cost private healthcare will continue driving new business models and opportunities, transforming the pharma and medtech landscape.

Join us to examine 2026 budgets, demand patterns, emerging opportunities, and practical scenarios for the next consolidated tender—leaving you fully prepared to safeguard margins and capture growth in both public and private healthcare markets.